Validation of Hematological Indices
Recruiting
N/A
Interventional Study
Multiple Organ Dysfunction
Sepsis
Pneumonia
Wound Infection
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
At a Glance
- Age
- 18 – 80
- Sex
- Any
- Study type
- Interventional
- Purpose
- Diagnostic
- Participants needed
- 200 (estimated)
- Sponsor
- Petrovsky National Research Centre of Surgery · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
The hypothesis of the study is that hematological indices (neutrophil to lymphocyte ratio, platelet to lymphocyte ratio and systemic index of inflammation) may be predictors of infectious complications and multiple organ dysfunction in patients after cardiac surgery.
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* age from 18 to 80 years
* cardiac surgery
* operation in the conditions of cardiopulmonary bypass
* availability of voluntary informed consent of the patient to participate in the study
Exclusion Criteria:
* refusal of the patient from the study
* transfer of the patient to …
Contacts